ANI Pharmaceuticals, Inc. Reports Record Net Revenues Of $10.5 million, EPS From Continuing Operations Of $0.35, And Adjusted Non-GAAP EBITDA Of $3.9 Million For The Fourth Quarter Ended December 31, 2013
2/18/2014 8:38:57 AM
BAUDETTE, Minn., Feb. 18, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (ANIP) today reported financial results for the three and twelve months ended December 31, 2013.
Fourth quarter highlights include:
•Fourth quarter record net revenues of $10.5 million, an increase of 98% as compared to $5.3 million for the same period in 2012.
Help employers find you! Check out all the jobs and post your resume.
comments powered by